Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2009-02-03
Target enrollment:
Participant gender:
Summary
This is an open-label extension to study 49653/461, to assess the long-term safety of
rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's
Disease.